by Jessica Casebolt | Mar 29, 2023 | Life Sciences, Tea Leaves
The Food and Drug Administration scheduled a May advisory meeting to discuss if HRA Pharma’s birth control pill should be available over the counter, an approval that would be the first of its kind from the agency. FDA advisers originally planned to review the...
by Jessica Casebolt | Mar 28, 2023 | Tea Leaves, Transition to Value
Wellvana Health, a value-based care technology company that assumes downside risk for partner physicians through an underwriting program, has reached $84 million in a series B round of funding. The investment was co-led by Heritage Group and Valtruis with...
by Jessica Casebolt | Mar 28, 2023 | Opioid/Substance Use Disorders, Tea Leaves
A Pennsylvania program that incorporates addiction treatment into emergency care for opioid use disorder could help limit the high risk of death for patients who overdose after they’re discharged, according to a study published in JAMA Health Forum. Emergency...
by Jessica Casebolt | Mar 28, 2023 | M&A, Tea Leaves
CVS Health is set to close its major acquisition of health services company Signify Health this week in adeal valued at $8 billion. The acquisition will help advance the health giant’s push into value-based care. It is the latest bid by CVS to get further into health...
by Jessica Casebolt | Mar 28, 2023 | Access & Coverage, Tea Leaves
22 Democratic lieutenant governors are forming a coalition built around protecting abortion access in their states that will likely involve crafting model executive orders and legislation. The Reproductive Freedom Coalition, led by Connecticut Lt. Governor Susan...
Recent Comments